Dr. Katherine Mathews, MD
Claim this profileUniversity of Iowa Hospitals and Clinics
Expert in Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
16 reported clinical trials
14 drugs studied
Area of expertise
1Muscular Dystrophy
Global LeaderDMD negative
DMD positive
FKRP positive
2Duchenne Muscular Dystrophy
DMD negative
DMD positive
FKRP positive
Affiliated Hospitals
Clinical Trials Katherine Mathews, MD is currently running
Gene Therapy
for Duchenne Muscular Dystrophy
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is a randomized, double-blind, placebo-controlled 2-part study. Participants will be in the study for approximately 128 weeks. All participants will have the opportunity to receive intravenous (IV) delandistrogene moxeparvovec in either Part 1 or Part 2.
Recruiting1 award Phase 35 criteria
Tideglusib
for Myotonic Dystrophy
This trial tests tideglusib, a medication, in children and adolescents with Congenital or Childhood Onset Myotonic Dystrophy. It aims to improve muscle function by targeting specific body processes. The study includes both those who participated in a previous study and those who have not been treated before.
Recruiting1 award Phase 2 & 31 criteria
More about Katherine Mathews, MD
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Katherine Mathews, MD has experience with
- Placebo
- Tideglusib
- SRP-9001 (Delandistrogene Moxeparvovec)
- Observational Study
- Corticosteroids
- Pamrevlumab
Breakdown of trials Katherine Mathews, MD has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Retinitis Pigmentosa
Friedreich Ataxia
Congenital Cerebellar Ataxias
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katherine Mathews, MD specialize in?
Katherine Mathews, MD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved DMD negative patients, or patients who are DMD positive.
Is Katherine Mathews, MD currently recruiting for clinical trials?
Yes, Katherine Mathews, MD is currently recruiting for 5 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Katherine Mathews, MD has studied deeply?
Yes, Katherine Mathews, MD has studied treatments such as Placebo, Tideglusib, SRP-9001 (Delandistrogene Moxeparvovec).
What is the best way to schedule an appointment with Katherine Mathews, MD?
Apply for one of the trials that Katherine Mathews, MD is conducting.
What is the office address of Katherine Mathews, MD?
The office of Katherine Mathews, MD is located at: University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa Hospitals and Clinics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.